Irish Journal of Medical Science

, Volume 182, Issue 3, pp 415–419 | Cite as

Parkinson’s disease: how is employment affected?

  • R. MurphyEmail author
  • N. Tubridy
  • H. Kevelighan
  • S. O’Riordan
Original Article



Rates of unemployment and early retirement are increased in Parkinson’s disease (PD) and contribute to disease burden.


To investigate time to loss of employment from PD onset and predictors of continued employment; to identify common issues and possible interventions in the workplace.


Eighty-eight patients with PD diagnosed at age ≤65 years took part in a retrospective cohort study. Veterans RAND Short Form-36 and an employment survey were administered.


Unemployment rates for males were increased compared to the general Irish population (standardized ratio of 1.6, 95 % CI 1.2–2.2, P < 0.05). There was no significant difference for females. Median retirement age was 58 years for males and 61 years for females compared to 63.5 and 65 years, respectively, in the general population. In survival analysis, median time to loss of employment was 7 years (95 % CI 4.8–9.2). After 5 years, 40 % remained working and 14 % after 10 years. Early age of PD onset (P < 0.001), early diagnosis (P < 0.002) and high scores in vitality (P < 0.005) were associated with prolonged employment. There was no association with sex, education, type or hours of work. Slowness, fatigue and tremor were the most challenging symptoms at work. Changes in work schedule and type of work were suggested helpful adjustments.


Loss of employment places a significant socioeconomic burden on young PD patients. More detailed examination of specific issues and reasonable adjustments is needed, along with patient and employer education.


Parkinson’s disease Young Socioeconomic Financial Employment 



We would like to thank Prof. Leslie Daly, chairman of CSTAR, for his valuable help in writing this paper and all those who generously agreed to participate in this study.

Conflict of interest



  1. 1.
    Wickremaratchi M, Perera D, O’Loghlen C et al (2009) Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry 80:805–807PubMedCrossRefGoogle Scholar
  2. 2.
    Schrag A, Hovris A, Morley D et al (2003) Young- versus older-onset Parkinson’s disease: impact of disease and psychosocial consequences. Mov Disord 18:1250–1256PubMedCrossRefGoogle Scholar
  3. 3.
    Calne SM, Kumar A (2008) Young onset Parkinson’s disease. Practical management of medical issues. Parkinsonism Relat Disord 14(2):133–142PubMedCrossRefGoogle Scholar
  4. 4.
    Calne SM, Lidstone SC, Kumar A (2008) Psychosocial issues in young-onset Parkinson’s disease: current research and challenges. Parkinsonism Relat Disord 14:143–150PubMedCrossRefGoogle Scholar
  5. 5.
    Schrag A, Banks P (2006) Time of loss of employment in Parkinson’s disease. Mov Disord 21:1839–1843PubMedCrossRefGoogle Scholar
  6. 6.
    Martikainen KK, Luukkaala TH, Marttila RJ (2006) Parkinson’s disease and working capacity. Mov Disord 21:2187–2191PubMedCrossRefGoogle Scholar
  7. 7.
    Jasinska-Myga B, Heckman MG, Wider C et al (2012) Loss of ability to work and ability to live independently in Parkinson’s disease. Parkinsonism Relat Disord 18:130–135PubMedCrossRefGoogle Scholar
  8. 8.
    Banks P, Lawrence M (2006) The Disability Discrimination Act, a necessary, but not sufficient safeguard for people with progressive conditions in the workplace? The experiences of younger people with Parkinson’s disease. Disabil Rehabil 28:13–24PubMedCrossRefGoogle Scholar
  9. 9.
    Forsaa EB, Larsen JP, Wentzel-Larsen T et al (2008) Predictors and course of health-related quality of life in Parkinson’s disease. Mov Disord 23:1420–1427PubMedCrossRefGoogle Scholar
  10. 10.
    Karlsen KH, Tandberg E, Årsland D, Larsen JP (2000) Health related quality of life in Parkinson’s disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 69:584–589PubMedCrossRefGoogle Scholar
  11. 11.
    Garratt A, Schmidt L, Mackintosh A et al (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324:1417PubMedCrossRefGoogle Scholar
  12. 12.
    McHorney CA, War JE Jr, Lu JFR et al (1994) The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40–66PubMedCrossRefGoogle Scholar
  13. 13.
    McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247–263PubMedCrossRefGoogle Scholar
  14. 14.
    Ware JE Jr, Sherbourne CD (1992) The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRefGoogle Scholar
  15. 15.
    Damiano AM, McGrath MM, Willian MK et al (2000) Evaluation of a measurement strategy for Parkinson’s disease: assessing patient health-related quality of life. Qual Life Res 9:87–100PubMedCrossRefGoogle Scholar
  16. 16.
    Rubenstein LM, Voelker MD, Chrischilles EA et al (1998) The usefulness of the functional status questionnaire and medical outcomes study short form in Parkinson’s disease research. Qual Life Res 7:279–290PubMedCrossRefGoogle Scholar
  17. 17.
    Women and men in Ireland 2010 (2011). Central Statistics OfficeGoogle Scholar
  18. 18.
    This is Ireland highlights from census 2011, part 2 (2012). Central Statistics OfficeGoogle Scholar
  19. 19.
    Huse DM, Schulman K, Orsini L et al (2005) Burden of illness in Parkinson’s disease. Mov Disord 20:1449–1454PubMedCrossRefGoogle Scholar
  20. 20.
    Winter Y, Balzer-Geldsetzer M, Spottke A et al (2010) Longitudinal study of the socioeconomic burden of Parkinson’s disease in Germany. Eur J Neurol 17:1156–1163PubMedCrossRefGoogle Scholar
  21. 21.
    Jennum P, Zoetmulder M, Korbo L et al (2011) The health-related, social, and economic consequences of Parkinsonism: a controlled national study. J Neurol 258:1497–1506PubMedCrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2013

Authors and Affiliations

  • R. Murphy
    • 1
    Email author
  • N. Tubridy
    • 2
  • H. Kevelighan
    • 2
  • S. O’Riordan
    • 2
  1. 1.UCD School of Medicine and Medical SciencesDublin 4Ireland
  2. 2.Department of NeurologySt. Vincent’s University HospitalDublin 4Ireland

Personalised recommendations